Cargando…
Study Design and Cohort Comparability in a Study of Major Cardiovascular Events in New Users of Prucalopride Versus Polyethylene Glycol 3350
INTRODUCTION: Given prior safety experience with other 5-HT(4) agonists for chronic constipation, an observational, population-based cohort study in five data sources from Germany, Sweden, and the UK was conducted to evaluate the cardiovascular safety of prucalopride. OBJECTIVES: Our objective is to...
Autores principales: | Fortuny, Joan, Gilsenan, Alicia, Cainzos-Achirica, Miguel, Cantero, Oscar F., Flynn, Robert W. V., Garcia-Rodriguez, Luis, Kollhorst, Bianca, Karlsson, Pär, Linnér, Love, MacDonald, Thomas M., Plana, Estel, Ruigómez, Ana, Schink, Tania, Ziemiecki, Ryan, Andrews, Elizabeth B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739282/ https://www.ncbi.nlm.nih.gov/pubmed/31134513 http://dx.doi.org/10.1007/s40264-019-00836-z |
Ejemplares similares
-
Cardiovascular Safety of Prucalopride in Patients with Chronic Constipation: A Multinational Population-Based Cohort Study
por: Gilsenan, Alicia, et al.
Publicado: (2019) -
Identification and Validation of Major Cardiovascular Events in the United Kingdom Data Sources Included in a Multi-database Post-authorization Safety Study of Prucalopride
por: Ruigómez, Ana, et al.
Publicado: (2021) -
Polyethylene Glycol 3350 With Electrolytes Versus Polyethylene Glycol 4000 for Constipation: A Randomized, Controlled Trial
por: Bekkali, Noor L.H., et al.
Publicado: (2018) -
Antifibrotic preventive effect of polyethylene glycol (PEG) 3350 in methotrexateinduced hepatoxicity model
por: Acar, Hüseyin, et al.
Publicado: (2022) -
Safety of polyethylene glycol 3350 solution in chronic constipation: randomized, placebo-controlled trial
por: McGraw, Thomas
Publicado: (2016)